Last updated on November 2017

A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.


Brief description of study

A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.

Detailed Study Description

The purpose of this study is to assess the effect of vedolizumab in the subcutaneous form.

Clinical Study Identifier: TX15247

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )